Thursday, October 13, 2005

Wyeth phases out NY facility

12/10/2005 - Pharmaceutical manufacturers, Wyeth, are to phase out manufacturing at its US facility as part of its consolidation plans, which will see the gradual phasing out of all operations at the New York facility by late 2008.

The three-year transition plan aims to phase out production of over-the-counter drugs as well as some of the best-selling ethical drugs currently on the market. The facility, located at Rouses Point, New York, manufactures and packages all dosage forms, from solid dosage to sterile fills.

pharmatech link to full story

No comments: